Dexmedetomidine Versus Fentanyl for Sedation of Postoperative Mechanically Ventilated Neonates
Primary Purpose
Postoperative Pain
Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Dexmedetomidine
Fentanyl
Sponsored by
About this trial
This is an interventional treatment trial for Postoperative Pain
Eligibility Criteria
Inclusion Criteria:
- Neonates need postoperative ventilation.
Exclusion Criteria:
- Major congenital cardiovascular anomalies.
- Chromosomal anomalies.
- Grade IV intraventricular hemorrhage.
- Tracheoesophageal fistula with wide gap (distance between proximal and distal end more than two centimeters).
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Fentanyl
Dexmedetomidine
Arm Description
Neonates received fentanyl infusion during postoperative phase.
Neonates received dexmedetomidine infusion during postoperative phase.
Outcomes
Primary Outcome Measures
The efficacy of postoperative sedation according to pain score.
Assessment of Neonatal Pain, Agitation and Sedation Scale immediately after the operations then every 12 hours till 5 days
Secondary Outcome Measures
Plasma cortisol level
Plasma as a base line after the operation and another two measures one after 24 hours from the operation and the other after 48 hours
Need of adjuvant analgesics or sedatives
Infants in both groups received open-label intravenous fentanyl boluses at a dose of 1µg/kg, as adjuvant analgesic when the pain score was more than 3 points. The dose was repeated, based on pain score assessment, at a minimum interval of 2-4 hours. Also, both groups received midazolam bolus at a dose of 0.1 mg/ kg/dose IV as adjuvant sedative in both groups when the patient was agitated.
Need of skeletal muscle relaxant
Neonates in both groups received Pancuronium at a dose of 0.1 mg/ kg /dose IV as a skeletal muscle relaxant when two boluses of midazolam failed to control agitation
Time to extubation.
Days upon mechanical ventilation
Time to reach 100ml/kg/day enteral feed.
Days to reach 100ml/kg/day enteral feed.
Length of hospital stay.
Days of hospital admission
Mortality
Death
Adverse effects of the sedative drugs
Hypotension, bradycardia, chest wall rigidity, feeding intolerance withdrawal signs,re-intubation within 48 hours
Culture-proven sepsis
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05324891
Brief Title
Dexmedetomidine Versus Fentanyl for Sedation of Postoperative Mechanically Ventilated Neonates
Official Title
Dexmedetomidine Versus Fentanyl for Sedation of Postoperative Mechanically Ventilated Neonates
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
January 2016 (Actual)
Primary Completion Date
August 2017 (Actual)
Study Completion Date
August 30, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mansoura University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Newborn infants experience pain after surgical procedures,prevention and management of pain in neonates is important due to its deleterious consequences. Fentanyl is a widely used analgesic which promotes rapid analgesia,however, is not free of adverse effects including chest wall rigidity, hypothermia, hypotension, respiratory depression and tolerance.Dexmedetomidine is a selective α 2-adrenergic agonist can cause sedation, anxiolysis, analgesia and minimal respiratory depression.Therefore, the objective of the study is to evaluate the safety and efficacy of dexmedetomidine compared to fentanyl in postoperative mechanically ventilated neonates.
Detailed Description
A prospective, randomized trial, which was conducted upon neonates who needed postoperative mechanical ventilation in Neonatal Intensive Care Unit, Mansoura University Children's Hospital.The patients were randomized to two groups according to the drug they received for postoperative sedation. The first group received dexmedetomidine infusion and the second group received fentanyl infusion.Our primary outcome was the efficacy of postoperative sedation score, and the secondary outcomes were plasma cortisol level, time to extubation, time to reach 100ml/kg enteral feed, need for adjuvant sedative and skeletal muscle relaxant, length of the hospital stay, side effects of sedative drugs and mortality.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Fentanyl
Arm Type
Active Comparator
Arm Description
Neonates received fentanyl infusion during postoperative phase.
Arm Title
Dexmedetomidine
Arm Type
Active Comparator
Arm Description
Neonates received dexmedetomidine infusion during postoperative phase.
Intervention Type
Drug
Intervention Name(s)
Dexmedetomidine
Intervention Description
Infants received dexmedetomidine IV loading dose: 0.5 mcg/kg given over 20 minutes followed by maintenance dose 0.3 µg/kg/hour by infusion over 24 hours.Weaning was done when the patient was about to be extubated or with maximum 5 days after the randomization.
Intervention Type
Drug
Intervention Name(s)
Fentanyl
Intervention Description
Infants received Fentanyl IV continuous infusion: 1µg/ kg /hour. Weaning was done when the patient was about to be extubated or with maximum 5 days after the randomization.
Primary Outcome Measure Information:
Title
The efficacy of postoperative sedation according to pain score.
Description
Assessment of Neonatal Pain, Agitation and Sedation Scale immediately after the operations then every 12 hours till 5 days
Time Frame
upto five days after surgical intervention
Secondary Outcome Measure Information:
Title
Plasma cortisol level
Description
Plasma as a base line after the operation and another two measures one after 24 hours from the operation and the other after 48 hours
Time Frame
Within 48 hours after surgical intervention
Title
Need of adjuvant analgesics or sedatives
Description
Infants in both groups received open-label intravenous fentanyl boluses at a dose of 1µg/kg, as adjuvant analgesic when the pain score was more than 3 points. The dose was repeated, based on pain score assessment, at a minimum interval of 2-4 hours. Also, both groups received midazolam bolus at a dose of 0.1 mg/ kg/dose IV as adjuvant sedative in both groups when the patient was agitated.
Time Frame
upto five days after surgical intervention
Title
Need of skeletal muscle relaxant
Description
Neonates in both groups received Pancuronium at a dose of 0.1 mg/ kg /dose IV as a skeletal muscle relaxant when two boluses of midazolam failed to control agitation
Time Frame
upto five days after surgical intervention
Title
Time to extubation.
Description
Days upon mechanical ventilation
Time Frame
upto 21 days postoperative
Title
Time to reach 100ml/kg/day enteral feed.
Description
Days to reach 100ml/kg/day enteral feed.
Time Frame
upto 21 days postoperative
Title
Length of hospital stay.
Description
Days of hospital admission
Time Frame
upto 30 days postoperative
Title
Mortality
Description
Death
Time Frame
upto 21 days postoperative
Title
Adverse effects of the sedative drugs
Description
Hypotension, bradycardia, chest wall rigidity, feeding intolerance withdrawal signs,re-intubation within 48 hours
Time Frame
upto seven days after surgical intervention
Title
Culture-proven sepsis
Time Frame
upto 30 days after surgical intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Hour
Maximum Age & Unit of Time
4 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Neonates need postoperative ventilation.
Exclusion Criteria:
Major congenital cardiovascular anomalies.
Chromosomal anomalies.
Grade IV intraventricular hemorrhage.
Tracheoesophageal fistula with wide gap (distance between proximal and distal end more than two centimeters).
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Dexmedetomidine Versus Fentanyl for Sedation of Postoperative Mechanically Ventilated Neonates
We'll reach out to this number within 24 hrs